A renowned UCSD eye doctor who is part of a Chinese recruitment program under FBI scrutiny has resigned amid inewsource’s questions about his foreign government affiliations and businesses.
inewsource has learned that Kang Zhang, the former chief of eye genetics at the UCSD Shiley Eye Institute, is a member of the Thousand Talents Program, which the FBI says incentivizes scientists to illegally take intellectual property developed at U.S. universities to China. The purpose, authorities say, is to advance the country’s “scientific, economic, and military development goals.”
Over the past few years U.S. intelligence agencies have grown increasingly concerned by foreign government efforts to influence and incentivize American researchers to take intellectual property abroad.
Authorities and universities across the country are beginning to crack down on academics they believe have participated in illicit or illegal actions.
Why this matters
In recent years, U.S. intelligence agencies have grown increasingly concerned about foreign government efforts to influence and incentivize American researchers to take intellectual property abroad. Authorities and universities across the country are investigating academics they believe have participated in these kinds of activities.
Our reporting has also uncovered Zhang is the founder and primary shareholder of a publicly traded Chinese biotechnology company that specializes in the same work he performed at the University of California San Diego.
He has not disclosed this and his other Chinese pharmaceutical businesses to the U.S. government or UCSD on forms required by university policy and federal regulations. Our reporting has not uncovered any accusation that Zhang illegally took intellectual property abroad.
Zhang resigned from the university Thursday after inewsource posed questions to his attorney and UCSD about the doctor’s connections to the Thousand Talents Program and undisclosed Chinese businesses.
This portrait of Zhang exists within Chinese business filings, archived websites in Mandarin, real estate documents and divorce records.
Zhang’s attorney, Leo Cunningham, told inewsource in an email on Tuesday his client “was never asked to conceal his involvement with the Thousand Talents program; he never did conceal his involvement; there was nothing improper about his involvement; and he had no reason to conceal his involvement.”
Most if not all of Zhang’s companies “have been long known” to the university, Cunningham said, though he provided no evidence. He said in an email Friday that Zhang’s reasons for resigning “are between the doctor and the University.”
Dr. Ross McKinney, the chief scientific officer at the Association of American Medical Colleges, said Zhang’s lack of disclosures is troubling.
“Not telling it is lying, pure and simple, and is unconscionable,” said McKinney, adding “You have the exact paradigmatic case of what can and has gone wrong.”
After an inewsource investigation in April found Zhang put research participants in harm’s way for years, a UCSD spokeswoman said Zhang was “on leave” and the university was reviewing his activities.
UCSD officials have declined, despite repeated requests, to say whether they’ve known of Zhang’s business interests overseas.
They also wouldn’t say whether they received a letter from the National Institutes of Health recommending an investigation into Zhang, who has brought in more than $15 million in NIH grants over his career – about $10 million of it during his 11 years at UCSD – for research on eye disease and genetics.
As of June, the NIH’s Office of Extramural Research had notified more than 60 universities and grantee institutions over concerns of undisclosed conflicts of interest and affiliations among researchers. The letters have prompted grant refunds, terminations, suspensions and FBI involvement.
“Those letters are sent out where we have concerns that there may be problems with noncompliance – noncompliance meaning that there was not proper disclosure of important information to us,” Michael Lauer, an NIH deputy director, told inewsource in June.
The NIH is the largest public funder of biomedical research in the world, investing around $39 billion annually. Lauer helps oversee its scientific integrity in research funding as well as grant compliance and public accountability. He said the agency has seen significant conflicts of interest where researchers who received NIH funding for their projects also have a financial stake in foreign companies developing the same technologies.
“In some cases, these are startup companies that they themselves founded,” Lauer said.
It is not illegal or uncommon for scientists to own businesses or be involved in talent recruitment programs. According to a recent study, nearly 1,000 government and private industry employees have taken Thousand Talents money.
Cunningham said Zhang declined an offer to participate in the program full time and did not accept payment from the Chinese government.
inewsource has identified a dozen other members of the Thousand Talents Program at research institutions in San Diego but has not yet confirmed details about their activities.
Critics of the U.S. crackdown decry a new McCarthyism.
Michael Zigmond, an ethics expert and retired professor of neurology at the University of Pittsburgh School of Medicine, is one of them. Zigmond lectured at China’s Fudan University for more than 15 years, has many colleagues in the U.S. who came from China, and believes this is all a “misdirected concern” — a way of targeting China that will backfire.
Inevitably, he said, universities will lose students, researchers and funding, and patients will suffer.
“Certainly countries spy on each other, and the United States does its share of spying,” he said.
“But to suggest that biomedical science is a target area for this kind of thing, I think, is crazy. We all report our results in annual progress reports, at professional meetings, and in published papers. Stealing secrets is the last thing from our minds,” Zigmond said.
But the NIH and FBI have growing concerns.
In April, FBI Director Christopher Wray summarized the agency’s viewpoint to the Council on Foreign Relations, a nonpartisan think tank.
“More than ever, the adversaries’ targets are our nation’s assets — our information and ideas, our innovation, our research and development, our technology,” Wray said during his speech.
“And no country poses a broader, more severe intelligence collection threat than China,” he said.
Zhang’s life abroad
Kang Zhang was born near the start of China’s Cultural Revolution in 1963, a period when scientists and other intellectuals were condemned as capitalistic. Universities were shuttered, scientific training ceased and the brightest minds were sent to the countryside “to learn the value of political virtue.”
That revolution, according to the Chinese Communist Party, “was responsible for the most severe setback and the heaviest losses suffered by the Party, the state and the people since the founding of the People’s Republic.”
To reverse the damage, China sent scientists to train and study overseas starting in the 1980s. Many didn’t return, so the party created talent recruitment programs to bring them back through financial incentives.
The most successful has been the Thousand Talents Program, which began in 2008. The goal was to return 2,000 high-quality academics to China over the next 10 years by offering competitive salaries, state-of-the-art facilities, honorary titles and a one-time payment of around $145,000.
It worked. Recruitment now exceeds 7,000 members.
McKinney – talking about the program and not about Zhang – said, “It appears that the Thousand Talents Program would hire faculty members for big blocks of time – six months was fairly typical – and tell the faculty member not to tell their host institution.” He added, “There’s very concrete evidence that, basically, the faculty were being instructed to lie – and did lie.”
Zhang was selected among the third batch of recruits in 2010, two years into his job at UCSD, where he was the founding director of the Institute for Genomic Medicine. After his recruitment, Chinese news releases and interviews involving Zhang often included his Thousand Talents affiliation.
Around that time, Zhang created a pharmaceutical research and development company called CalCyte Therapeutics. San Diego philanthropist Richard Hertzberg helped fund the company shortly after its formation and later became its president.
CalCyte applied for and received two NIH small-business grants worth nearly half a million dollars to develop treatments for age-related macular degeneration – the leading cause of vision loss for those 50 and older and a primary focus of Zhang’s work.
In 2010, Hertzberg helped fund a conference in translational medicine in Shenzhen, China, in collaboration with UCSD and Peking University. Zhang was among the event’s three chairmen, and UCSD Vice Chancellor for Health Sciences Dr. David Brenner was one of the honored chairmen.
“That was the world at its best – knowledgeable people in conversation trying to help all of mankind,” Hertzberg told inewsource, “and that conference never would have happened without Kang Zhang and his hard work.
“I hope that we have not seen the last of that kind of conference,” he said.
Though CalCyte contracted with UCSD for its research, Zhang didn’t mention the company in his conflict of interest disclosures with UCSD’s Shiley Eye Institute. In fact, Shiley never collected disclosures from Zhang despite university and federal requirements.
On Tuesday, before Zhang resigned, his lawyer told inewsource Zhang has discussed disclosure expectations “at length” with UCSD.
“His present understanding of those expectations is different from his prior understanding, and his disclosures would be different going forward,” Cunningham said. “However, even if he had disclosed the relationships you have identified, that should not have made any difference in the conduct of UCSD or the awarding of grants.”
In 2012, with CalCyte’s grant-funded work complete, Zhang founded the publicly traded Guangzhou Kangrui Biological Pharmaceutical Technology Co. in China – KangRui Bio for short – with a $1.5 million investment.
Today, KangRui Bio provides its customers with “research in ophthalmology and genetics, including limbal stem cell therapy, new drug development for ophthalmology, research and development of kits for genetic testing related to ophthalmology, and related technology transfer, service and reagent sales.”
According to KangRui’s website, which was taken offline but archived, Zhang is the driving force behind the enterprise, honored by the Chinese minister of health as “the elite of our nation.“
KangRui Bio’s 2017 semiannual report declared $11.7 million in assets, with Zhang owning 50% of the company’s shares.
Zhang’s lawyer said the doctor’s involvement in KangRui was publicly disclosed – in Mandarin business filings.
Hertzberg told inewsource, “I have funded Dr. Zhang’s research work at UCSD for nearly a decade. I believe that as a doctor and genetic scientist, his research objective was always to advance science in the pursuit of knowledge to cure macular degeneration and other afflictions.”
However, he added, “Prior to receiving your information, I had no knowledge of Dr. Zhang’s involvement in any Chinese corporation.”
A national snapshot
Since last year, scientists at Texas’ MD Anderson Cancer Center, Atlanta’s Emory University, New Mexico’s Los Alamos National Laboratory and the National Oceanic and Atmospheric Administration have resigned, been fired and even arrested as part of the federal investigation into foreign influence in science.
“There have been other occasions, but I’m not in a position to share that with you,” said Lauer, adding that the NIH has referred criminal concerns to the FBI and other federal agencies. An important point, he said, is that authorities are focusing on conduct and not ethnicities.
To that point, the U.S. Department of Energy in June banned employees from participating in foreign talent recruitment programs involving China, Iran, North Korea and Russia due to national security interests.
The turmoil has prompted China to remove the names of Thousand Talents affiliates from government and institutional websites and warn officials against mentioning the program by name.
As investigations ramp up, those involved must balance due diligence against inciting xenophobia toward the more than 1.4 million international scholars across U.S. college campuses – the vast majority of whom the FBI says pose no threat and have significantly advanced their fields.
“The whole thing is an incredible shame,” McKinney said. “We have had really good collaborations, and this is a poisoning of the trust that will make that harder, in spite of the value that institutions and people have gotten from those collaborations.”
McKinney came to the Association of American Medical Colleges in 2016 from Duke University, which suffered its own high-profile case of alleged intellectual property theft involving a former Chinese student years ago.
In retrospect, McKinney said he saw signs he didn’t recognize as a pattern during his time at Duke – faculty with “extended engagements overseas,” which may have been completely innocent but left him to “ponder and wonder.”
His association’s membership now includes more than 600 medical schools and centers, major teaching hospitals and Veterans Affairs systems. The association is teaching its members to be alert to systemic efforts to recruit or influence their faculty.
“I don’t think they closed their eyes because they didn’t want to know. I don’t think that they actually looked,” McKinney said.
He added that only after universities began investigating their own researchers did they discover “the NIH and the FBI are not exaggerating – there really is systematic dishonesty.”
Cross continents
Zhang was continuing his eye studies on human subjects at UCSD during KangRui Bio’s formation, though his work proved problematic time and again.
A university institutional review board, which is supposed to protect human research subjects, suspended enrollment in all 11 of Zhang’s studies in 2012 after receiving an anonymous complaint that he had committed multiple ethical, compliance and integrity violations in a study that enrolled more than 16,000 participants.
The investigation that followed found “extensive and pervasive” problems with Zhang’s work, but the UCSD review board allowed him to resume his research. Then, in 2016, the board again suspended enrollment in his studies for “significant regulatory and study noncompliance” after Zhang received a visit from the U.S. Food and Drug Administration.
That 2016 inspection found major problems with Zhang’s study, including enrolling ineligible subjects, missing drug records and jeopardizing subject safety and welfare. One of Zhang’s research subjects complained to UCSD that the doctor poked a hole in her eye during an injection because he was in a rush to catch a flight to China.
The FDA inspector noted that Zhang told her it was a bad time to conduct the inspection because it was “interfering with his vacation plans to China.”
UCSD stopped Zhang from serving as the lead scientist on human research in April 2017 but still allowed him to continue to apply for federal grants, publish in medical journals and train students until being suspended in April and resigning in July.
In the years between KangRui Bio’s formation and his 2017 reprimand, Zhang was establishing subsidiaries and additional companies in the U.S., China and the Cayman Islands:
- YouHealth Biotech was registered to Zhang’s La Jolla home in April 2015. Lianghong Zheng is the company’s CEO, chief financial officer and secretary. Zheng is a researcher at China’s Peking University, an executive at KangRui, and a co-author and patent holder with Zhang. YouHealth Biotech holds multiple patents with the University of California Board of Regents.
- YouHealth EyeTech is a wholly owned KangRui subsidiary created in February 2016. The company signed a $5 million deal soon after with Acucela, a U.S. clinical stage ophthalmology company that specializes in identifying and developing drugs to treat eye disease. Zhang has worked as a consultant for Acucela and sits on its advisory board.
- YouHealth AI formed in January 2018, registered to Zhang’s Del Mar home address. Its CEO is Yongtai Hou, chairman of the Shanghai Haohai Biotechnology Co. In a paper Zhang authored for the journal Cell, YouHealth AI was listed as having participated in the work. However, Zhang did not disclose his affiliation with the company even though his co-authors on the same article did.
- YouHealth Oncotech holds a patent with the UC Board of Regents for a method and system for determining cancer status, with Zhang as an inventor. It was formed in June 2016, but as a Cayman Island company its officers’ names are not public. A company with a similar name, YouHealth Ocutech, was registered in 2016 in Delaware, which also allows officers’ names to be kept private.
Mandarin searches through Google — along with China’s patent, university and government websites — show Zhang is involved in more biopharmaceutical companies abroad. Among them are Guangzhou Huibairui Biomedical Technology Co. and Guangzhou Youze Biological Pharmaceutical Technology Co.
inewsource could find no record Zhang disclosed these business interests in any UCSD document.
Philanthropist Hertzberg and his wife have provided major funding to UCSD for more than a decade and will continue to do so, he said.
“We believe that UCSD and institutions like it are the best bet we all have for making positive impacts on the big issues confronting mankind and the environment.”
But he said he and his wife “expect and rely upon UCSD to do its best to ensure that the programs are carried out ethically and in compliance with laws and regulations.”
More than a quarter of KangRui Bio’s shares are owned by Zhang’s wife, Rui Hou. She is KangRui’s general manager and a former teacher. She also works as the director or general manager of several other Zhang companies.
All told, the two and their affiliated corporations hold numerous patents across more than a dozen countries for stem cell cultivation, cancer diagnosis and aging modulation.
“Dr. Zhang’s China patents were known to UCSD, had no commercial value, were not based on research that was the subject of an NIH grant, and neither they, nor anything else he did, constituted a transfer of intellectual property to China,” said Cunningham, the doctor’s attorney.
Zhang’s companies were involved and cited in research that led to at least 12 articles he published in scientific journals, including Nature, Cell and Proceedings of the National Academy of Sciences.
Zhang did not disclose his relationship with these companies, nor did he declare any conflicts of interest, in any of those publications.
inewsource intern Lauren J. Mapp contributed to this report.
Correction: July 7, 2019
This story has been updated to correct that it was the National Institutes of Health’s Office of Extramural Research that notified more than 60 universities and grantee institutions over concerns of undisclosed conflicts of interest and affiliations among researchers.
- Editorial Standards Page
- Ethics Policy
- Diversity Statement
- Diversity Staffing Report
- Corrections Policy
- Ownership Structure, Funding
- Founding Date
- Masthead
- Mission Statement with Coverage Priorities
- Fact-checking Standards
- Unnamed Sources Policy
Editorial Standards Page
- Our Mission
- Ethics Policy
- Diversity
- Ownership Structure, Funding and Grants
- Financial Documents
- Fact-checking and Verification Standards
- Unnamed Sources
- Corrections and Clarifications
- Actionable Feedback and Newsroom Contacts
- Masthead
- Byline Policy
- The Trust Project
- Privacy Policy
Our Mission
inewsource is a nonprofit, nonpartisan newsroom dedicated to improving lives in the San Diego region and beyond through impactful, data-based investigative and accountability journalism.
Our Vision
Betrayals of the public trust are revealed and rectified, wrongdoing is deterred, and inequities are illuminated thanks to inewsource’s deep, dogged, fact-based reporting.
Our Values
Truth: Above all else, we value the importance of a free and credible press. Truth is the cornerstone of democracy and the core value for inewsource.
Transparency: We build trust with our readers by adhering to the highest standards and ethics, and to reporting with facts, precision and context.
Collaboration: Our newsroom prioritizes collaboration over competition. We regularly partner with media outlets on reporting projects and to share content.
Community: Our reporting serves the San Diego region, and we strive to build relationships with our audience by getting out into the community to listen and engage.
Ethics Policy
inewsource will conduct its business with the highest standards of decency, fairness and accuracy. These standards shall apply equally to inewsource employees, freelancers and all others engaged in gathering information on behalf of inewsource. All receive a copy of these ethical standards.
In the course of our reporting, we will consistently:
● Identify our organization and ourselves fully and avoid false representations of any kind to any source.
● Obtain consent from all parties before electronically recording any interview or conversation except in extraordinary cases authorized by the Managing Editor and Editor. If a source refuses to be taped, that must be honored; no recordings are to be made without consent.
● Respect the individual’s right to privacy. inewsource will never manipulate or barter private, personal, health, financial or other extraneous information in the course of preparing its reports.
● Any source we describe or write about in any significant manner must be contacted. The employee should document all efforts to contact the source, and if unsuccessful, should summarize these efforts at contact in the body of his/her writing.
In addition, inewsource follows the Code of Ethics of the Society of Professional Journalists. The latest version, revised in 2014, can be found here.
Editorial Independence Policy
We subscribe to standards of editorial independence adopted by the Institute for Nonprofit News (INN) as follows:
Our organization retains full authority over editorial content to protect the best journalistic and business interests of our organization. We will maintain a firewall between news coverage decisions and sources of all revenue. Acceptance of financial support does not constitute implied or actual endorsement of donors or their products, services or opinions.
We accept gifts, grants and sponsorships from individuals and organizations for the general support of our activities, but our news judgments are made independently and not on the basis of donor support. Our organization also may consider donations to support the coverage of particular topics, but our organization maintains editorial control of the coverage. We will cede no right of review or influence of editorial content, nor of unauthorized distribution of editorial content.
Our organization will make public all donors who give a total of $1,000 or more. We will accept anonymous donations for general support only if it is clear that sufficient safeguards have been put into place that the expenditure of that donation is made independently by our organization and in compliance with INN’s Membership Standards.
Diversity
Diverse Voices
Inclusiveness is at the heart of thinking and acting as journalists, and it supports the educational mandate of inewsource. Race, class, generation, gender, sexual orientation, ability, and geography all affect point of view. inewsource believes that reflecting societal differences in reporting leads to better, more nuanced stories and a better-informed community.
inewsource is committed to employment equity and diversity.
Diverse Staffing Report
Below is a breakdown of staffing data at inewsource. We determine the composition of our staff by asking them to self-identify. It is based on a newsroom of 11 and a total staff of 15 as of August 2020. Percentages are based on 15 total survey responses. The numbers include full-time and part-time staff, full-time fellows and full-time and part-time interns.
| All Staff Percentages are based on 15 total survey responses. The numbers include full-time and part-time staff, full-time fellows and full-time and part-time interns. | Newsroom Percentages are based on 15 completed survey responses to this question. | Business Percentages are based on 15 completed survey responses to this question. | |||
| Gender Identity | Gender Identity | Gender Identity | |||
| Women | 80% | Women | 82% | Women | 75% |
| Men | 20% | Men | 18% | Men | 25% |
| Sexual Orientation | Sexual Orientation | Sexual Orientation | |||
| Straight | 87% | Straight | 82% | Straight | 100% |
| LGBTQ-identifying | 7% | LGBTQ-identifying | 7% | ||
| Not specified | 7% | Not specified | 7% | ||
| Speak a language beyond English at home | 33% | Speak a language beyond English at home | 18% | Speak a language beyond English at home | 75% |
| Race/Ethnicity | Race/Ethnicity | Race/Ethnicity | |||
| White | 67% | White | 73% | White | 50% |
| Hispanic or Latinx | 20% | Two or more races | 18% | Hispanic or Latinx | 50% |
| Two or more races | 13% | Hispanic or Latinx | 9% | ||
| Age | Age | Age | |||
| 20-29 | 40% | 20-29 | 45% | 20-29 | 25% |
| 30-39 | 47% | 30-39 | 45% | 30-39 | 50% |
| 60 or older | 13% | 60 or older | 9% | 60 or older | 25% |
* The percentages in the charts have been rounded and may not add up to 100.
Ownership Structure, Funding and Grants
inewsource is a nonprofit organization, whose legal name is Investigative Newsource. It does business as inewsource. The business was incorporated on Aug. 4, 2009 in the state of California. Tax-exempt status as a 501c3 was granted by the IRS on Sept. 15, 2010. inewsource is funded primarily by individual contributions and foundation grants. We are guided by a board of directors.
Editorial independence: Journalists employed by inewsource take no editorial direction from donors whose contributions may support the organization. inewsource will not hesitate to report on its donors when events warrant. Our Editorial Independence Policy details the firewall between journalism and revenue.
To be transparent with the public, inewsource lists its donors on its website. In cases where a donor is the subject of an inewsource story, additional disclosure will be made.
Financial Documents
We do our due diligence to earn your trust in our reporting, as well as in our governance and financial sustainability. All of our financial documents are made available to view so that our supporters can trust we are sound stewards of your philanthropy. Review our IRS Form 990s, audited financial statements and annual reports:
Tax Returns
Financial Statements
Annual Reports
Fact-checking and Verification Standards
Transparency is one of our core values. Today, there is a need to build trust with our audience because new media and ways of communicating spread lies and slanted news faster than “real” news. At the same time, this era of new technologies makes it easier than ever for news organizations to be transparent. People don’t just have to believe us, they can investigate our investigations with our source materials.
Transparency is key to building credibility.
inewsource reporters have primary responsibility for reporting, writing, and fact-checking their stories. But before a story is published, the reporter reviews all facts and sources with an editor or another reporter. Facts must be traced to a primary source.
In addition, we “transparify” certain investigative stories. This process involves publishing a version of the web story with hyperlinks to all the story’s facts. This is proof that all facts have been documented with primary evidence. We do this to build trust with our readers and to be as transparent as we hope the public figures and institutions that we hold accountable will be.
Unnamed Sources
Not all sources are created equal. Some sources cannot speak authoritatively, provide proper analysis or speak specifically to every inquiry placed before them. To maintain the integrity of our reporting, inewsource reporters must select sources who can speak with validity to the topic at hand, and avoid presenting unqualified or underqualified sources as experts.
If an interviewed source has a conflict of interest, or whose qualifications may be tangential or limited, reporters will note that within the context of the story.
It is incumbent upon reporters to fully background their sources to uncover conflicts of interest or slant prior to using them in a story.
Unless discussed prior to an interview, all subjects talking to inewsource journalists are on the record. Specifically, the source is identified by name and title, and their exact or paraphrased words are attributed to them for publication. If journalists speak with sources who are not politicians, public figures or those not commonly interviewed by journalists, staff should explain clearly that information discussed will be on the record and for publication.
There are times, however, when information may be critical for a story but cannot be found or verified by other means. For example, a source may be able to confirm specific information about a series of events they may have witnessed, but have legitimate concerns about using their name or title. The repercussions to the source could be legal, job-related retribution or personal safety. The source and journalist must discuss these potential dangers and terms of use should be agreed upon by both parties.
If inewsource publishes information from an anonymous source, inewsource will explain to readers, in as much detail as possible, why we agreed to anonymity.
Corrections and Clarifications
inewsource strives for accuracy in everything we do, which is why we are committed to fact checking our content. But sometimes we make errors. When that happens, we correct them. We also clarify stories when something we’ve written is confusing or could be misinterpreted.
We endeavor to always be transparent about our commitment to correcting errors and clarifying misperceptions. When staffers see, hear or read about a possible issue with the accuracy of any inewsource content, they are expected to bring it to the attention of an editor and the web producer so it can be evaluated to determine how to proceed.
Including the web producer is key because inewsource is a multimedia news organization and shares its content with multiple partners on multiple platforms. The web producer must alert these partners about corrections and clarifications.
Corrections and clarifications should be included at the bottom of stories and dated.
Actionable Feedback and Newsroom Contacts
Our audiences know the region we cover and have a stake in maintaining and improving the quality of life in San Diego and Imperial counties. We know your knowledge and insights can help shape what we cover and how we cover it. We invite your comments and complaints on news stories, suggestions for issues to cover or sources to consult. We rely on you to tell us when we get it right and when we need to keep pushing.
Your comments, questions and suggestions can be sent to the team as a whole at contact@inewsource.org or you can contact a specific member of our staff.
Masthead
CEO, Editor and Founder: Lorie Hearn, loriehearn@inewsource.org
Lorie Hearn is the chief executive officer, editor and founder of inewsource. She founded inewsource in the summer of 2009, following a successful reporting and editing career in newspapers. She retired from The San Diego Union-Tribune, where she had been a reporter, Metro Editor and finally the senior editor for Metro and Watchdog Journalism. In addition to department oversight, Hearn personally managed a four-person watchdog team, composed of two data specialists and two investigative reporters. Hearn was a Nieman Foundation fellow at Harvard University in 1994-95. She focused on juvenile justice and drug control policy, a natural course to follow her years as a courts and legal affairs reporter at the San Diego Union and then the Union-Tribune.
Hearn became Metro Editor in 1999 and oversaw regional and city news coverage, which included the city of San Diego’s financial debacle and near bankruptcy. Reporters and editors on Metro during her tenure were part of the Pulitzer Prize-winning stories that exposed Congressman Randy “Duke” Cunningham and led to his imprisonment.
Hearn began her journalism career as a reporter for the Bucks County Courier Times, a small daily outside of Philadelphia, shortly after graduating from the University of Delaware. During the decades following, she moved through countless beats at five newspapers on both coasts.
High-profile coverage included the historic state Supreme Court election in 1986, when three sitting justices were ousted from the bench, and the 1992 execution of Robert Alton Harris. That gas chamber execution was the first time the death penalty was carried out in California in 25 years.
In her nine years as Metro Editor at the Union-Tribune, Hearn made watchdog reporting a priority. Her reporters produced award-winning investigations covering large and small local governments. The depth and breadth of their public service work was most evident in coverage of the wildfires of 2003 and then 2007, when more than half a million people were evacuated from their homes.
Managing Editor: Mark J. Rochester, markrochester@inewsource.org
Mark J. Rochester began as inewsource managing editor in April 2021, having served as editor in chief at Type Investigations, a nonprofit investigative newsroom in Manhattan. He was previously senior news director for investigations at the Detroit Free Press. Both newsrooms, he notes, shared a commitment to diversity and inclusion, and their investigative journalism often received national recognition for exposing problems impacting communities of color.
His family looks forward to returning to California, having spent more than seven years in San Francisco where Rochester was a senior manager for the Associated Press. While with the news cooperative, he led computer-assisted reporting training efforts around the West, both inside and outside of AP, and conducted a widely used analysis of the $74 million in campaign contributions that went toward the California gay marriage ballot initiative in 2008. The AP analyzed who gave and why and then made the data available to member newspapers. The resulting series of stories based on the data was AP’s 2009 Pulitzer nomination for Local Reporting.
Rochester, who served as a Pulitzer Prize jurist in 2017, also has held senior leadership positions at the Pittsburgh Post-Gazette, The Denver Post, Newsday and The Indianapolis Star. Rochester is vice president of Investigative Reporters & Editors Inc., the 6,000+ member international organization dedicated to improving investigative journalism. He also serves on the national advisory board of the Investigative Reporting Workshop at American University in Washington, D.C.
Managing Editor: Laura Wingard, laurawingard@inewsource.org
Laura Wingard is the managing editor at inewsource. She has been an editor in San Diego since 2002, working at The San Diego Union-Tribune, KPBS and now inewsource. At the Union-Tribune, she served in a variety of roles including as enterprise editor, government editor, public safety and legal affairs editor, and metro editor. She directed the newspaper’s award-winning coverage of the October 2007 wildfires and the 2010 disappearance of Poway teenager Chelsea King. She also oversaw reporting on San Diego’s pension crisis.
For two years, Wingard was news and digital editor at KPBS, overseeing a team of four multimedia reporters and two web producers. She also was the KPBS liaison with inewsource and collaborated with inewsource chief executive officer and editor Lorie Hearn on investigative work by both news organizations.
Wingard also worked at the Las Vegas Review-Journal as the city editor and as an award-winning reporter covering the environment and politics. She also was the assistant managing editor for metro at The Press-Enterprise in Riverside. She earned her bachelor’s degree at California State University, Fullerton, with a double major in communications/journalism and political science.
Byline Policy
Most of our articles carry a byline to identify the author. In some cases, inewsource will use a brand byline such as “Staff” or “inewsource” for internal or editorial information about the newsroom. In these instances, inewsource‘s Editor and Managing Editor are responsible for content that uses a brand byline.
The Trust Project
inewsource is proud to be a member of The Trust Project and support efforts to increase transparency in journalism by displaying the 8 Trust Indicators on our stories. We launched the Trust Indicators on Sep. 16, 2020.
Privacy Policy
inewsource has prepared this Privacy Policy to explain how we collect, use, protect, and share information when you use our inewsource.org website (the “Site“) or when you use any of our services (the “Services“).
By using the Site or Services you consent to this Privacy Policy.
Log Data
Like many site operators, we collect information that your browser sends whenever you visit our site (“Log Data”).
This Log Data may include information such as your computer’s Internet Protocol (“IP”) address, browser type, browser version, the pages of our site that you visit, the time and date of your visit, the time spent on those pages and other statistics.
Cookies
Cookies are files with small amount of data, which may include an anonymous unique identifier. Cookies are sent to your browser from a web site and stored on your computer or mobile device.
Like many sites, we use “cookies” to collect information. You can instruct your browser to refuse all cookies or to indicate when a cookie is being sent. However, if you do not accept cookies, you may not be able to use some portions of our site.
Certain pages on our site may set other third party cookies. For example, we may embed content, such as videos, from another site that sets a cookie. While we try to minimize these third party cookies, we can’t always control what cookies this third party content sets.
Additionally, we may use third party services — such as those that provide social media conveniences, measure traffic, send newsletters and facilitate donations — that may place cookies on your computer. We don’t have any way of knowing how such services handle the resulting data internally. inewsource makes no claim, nor takes liability for the insecure submission of information via these applications.
Here are the services whose cookies you can find on inewsource.org:
- Sharing buttons for Facebook and Twitter. These use the standard scripts provided by each company.
- Google Analytics, which we use to measure site traffic. Google Analytics gathers certain non-personally identifying information over time, such as your IP address, browser type, internet service provider, referring and exit pages, time stamp, and similar data. We also use Facebook Pixel to measure, optimize and build audiences for advertising campaigns served on Facebook. In particular it enables us to see how our users move between devices when accessing our website and Facebook, to ensure that our Facebook advertising is seen by our users most likely to be interested in such advertising by analyzing which content a user has viewed and interacted with on our website.
- Stripe, which allows us to accept donations through our website.
- Salesforce to manage newsletter subscriber, donor, and other identifiable user data.
- Mailchimp, to manage newsletter distributions. We collect your email address if you choose to subscribe to one of our email newsletters or email news alerts. Other optional information that you enter when subscribing – such as your first and last names or city are simply so that we can deliver more personalized email newsletters. We DO NOT sell, rent or market your information to any other parties. We retain your information only as long as necessary to provide your service. When we send emails, it collects some data about which users open the emails and which links are clicked. We use this information to optimize our email newsletters and, as aggregate information, to explain what percentage of our users open and interact with our newsletters.
Personal Data
We only collect personally identifiable information such as your name and email address when you sign up for a newsletter, donate to our organization, or otherwise submit it to us voluntarily. We do not share your personal data with any third parties other than some common service providers, whose products use your information to help us improve our site, deliver newsletters, or allow us to offer donation opportunities.
inewsource limits access to all user data for the purposes of newsletter, fundraising, and customer service only. User data is not sold to or otherwise shared with anyone not working with or for the inewsource.
You may unsubscribe or opt-out of our email and mail communications at any time by hitting the “unsubscribe” button in any email you receive from inewsource, or by emailing us at contact@inewsource.org or calling us at 619-594-5100.
Donor Information
The identities of all donors will be listed on our website. inewsource does not share, trade, sell, or otherwise release donors’ personal information to any third parties.
Refunds
If you encounter errors when donating on the website, please contact us at members@inewsource.org. For example, if you submit a donation for an incorrect amount or make a duplicate transaction please email us immediately so we can reverse the charges.
Cancellation of Recurring Donations
You can cancel your monthly recurring donations free of charge by notifying us at members@inewsource.org.
Links to Other Websites
Our site may contain links to documents, resources or other websites that we think may be of interest to you. We have no control over these other sites or their content. You should be aware when you leave our site for another, and remember that other sites are governed by their own user agreements and privacy policies, which should be available to you to read.
Disclaimers and Limitation of Liability
Although we take reasonable steps to prevent the introduction of viruses, worms, “Trojan Horses” or other destructive materials to our site, we do not guarantee or warrant that our site or materials that may be downloaded from our site are free from such destructive features. We are not liable for any damages or harm attributable to such features. We are not liable for any claim, loss or injust based on errors, omissions, interruptions or other inaccuracies on our site, nor for any claim, loss or injust that results from your use of this site or your breach of any provision of this User Agreement.
Contact Us
If there are any questions regarding this privacy policy, please contact us at contact@inewsource.org or call us at 619-594-5100.